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Editorial on the Research Topic
The Dynamic Interplay Between Nutrition, Autophagy and Cell Metabolism
Autophagy (derived from Greek words “auto” meaning self and “phagy” meaning eating) is a
physiological cellular program that removes unnecessary or dysfunctional components in an
orderly fashion (Dikic and Elazar, 2018; Platt, 2018). Autophagy allows the degradation and
recycling of cellular components. It modulates metabolism of lipids, proteins, or carbohydrates,
prevents accumulation of protein aggregates, removes damaged molecules and intracellular
organelles and therefore autophagy plays a prominent function in maintaining cell homeostasis,
inflammation, neurodegenerative disease and aging (Parenti et al., 2015; Dikic and Elazar, 2018;
Platt, 2018) (Figure 1).
The orderly degradation of cytoplasmic content generates by-products that are directly used in
many metabolic pathways, therefore autophagy is intimately linked to many metabolic pathways.
To emphasize the importance of autophagy in health and disease, we are presenting a Research
Topic containing a diversity of Review and Research Articles that shed new light on the molecular
mechanisms regulating the interplay between autophagy and cell metabolism in physiological and
pathological conditions.
Autophagy has been described in yeast, animals and plants and most of the autophagy related
genes (ATG) are conserved among different living organisms (Dikic and Elazar, 2018). In the
opening article of this Research Topic, Bu et al., discuss about the role of ATG8 in plant
autophagy. Multiple ATG8 orthologs have been identified in plants and the diversity within
the ATG8 family may suggest that they are involved in various functions in plants autophagy.
More specifically, ATG8 proteins undergo conjugation to phosphatidylethanolamine and regulate
membrane elongation during autophagosome biogenesis. This is a process that serves as an
important catabolic mechanism in plant growth and development, as well as in plant responses
to stress. ATG8s play a role in cargo recognition for selective autophagy by interacting with
autophagy receptors/adaptors to target specific substrates for degradation. But the exact roles of
ATG8 in plants intracellular trafficking are still poorly characterized. In addition, ATG8 proteins
play non-autophagic roles, such as plant senescence control, by interacting with specific proteins.
Nevertheless, the broad spectrum of ATG8 functions is yet to be completely clarified.
In another review article focusing on lipid metabolism, Xie et al. discuss the complex interplay
between lipid metabolism and autophagy. This interplay is important for the maintenance of cell
homeostasis through modulation of cell survival and death. Although lipid metabolism is crucial in
the formation of membrane structures that constitute the autophagosome—the double-membrane
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FIGURE 1 | Autophagy has important functions in organelle maintenance, protein turnover, and cellular stress; Therefore, autophagy contributes to the maintenance
of cellular homeostasis. As a consequence, any defect in such protective functions would result in the development of many human conditions including cancer,
inflammation, and neurodegenerative disease.
sequestering vesicles hallmark of autophagy—autophagy
per se has been found to promote lipid catabolism and
lipid peroxidation-induced cell death, such as ferroptosis. A
complex connection linking fatty acids, triglyceride, cholesterol,
membrane lipids biosynthesis, nutrition status, and autophagy
has been also found. The dysfunction of autophagy-dependent
lipid catabolism is implicated in several pathologic conditions
including steatosis, non-alcoholic fatty liver disease, Parkinson’s
disease and metabolic syndrome. On this regard, autophagy has
been taken in consideration as a target for the treatment of several
diseases. Here, the authors suggest that a better understanding
of the mechanisms underlining the interplay between autophagy
and lipid metabolism would promote potential treatments for
lipid metabolism-related disorders. However, many questions
remain to be addressed including: how autophagy functions in
regulating lipid metabolism in different cells? How autophagy
switch from pro-survival to pro-death signal? How selective is
autophagy in controlling cell-death?
A review article by Stacchiotti and Corsetti provides an in-
depth view of the age-related neurodegeneration, that leads to
severe diseases affecting motility, memory, cognitive function,
and social life. To date, there is a lack of effective treatments
for neurodegeneration and the consequent irreversible neuronal
loss. Considering that aberrant autophagy is involved in aging
and neurodegeneration, its targeting may represent a possible
strategy to fight or prevent age-related neurodegeneration.
Many natural compounds such as polyphenols, flavonoids,
polyamine, and sugars, limit brain damage in vitro and in
vivo and are modulators of autophagy. Their activity leads to
restoration of efficient autophagy thus promoting degradation
of misfolded proteins and of dysfunctional mitochondria. Many
studies have reported the efficacy of natural compounds in
enhancing or restoring autophagy in Alzheimer, Parkinson and
Huntington disease preclinical rodent models. However, an
enhanced autophagy may be deleterious in forebrain axons,
affecting retrograde flux and function. These evidences indicate
that in the brain an enhanced autophagy may not be always
beneficial. Unfortunately, a limitation to the development of
autophagy modulators for therapeutic intervention in humans is
that the currently available methods to measure the autophagic
flux are not efficient and consequently the generation of natural
drug’s efficacy in modulating autophagy is complex.
We were also enthusiastic to read a research article by
Marzetti et al. discussing physical frailty and sarcopenia (PF&S),
a human condition characterized by reduced physical function
and low muscle mass in the elderly. In their work, the authors
analyzed the relationship between three processes that are
thought to be involved in PF&S: systemic inflammation, amino
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acid dysmetabolism and mitochondrial dysfunction. The studies
took advantage of a cohort of old adults recruited in the
“BIOmarkers associated with Sarcopenia and Physical frailty in
EldeRly pErsons” (BIOSPHERE) study to evaluate inflammatory
biomolecules, amino acids and derivatives, and mitochondrial-
derived vesicle (MDV) cargo molecules as possible biomarkers
for PF&S. The idea behind this primary research was the
evaluation of these biomarkers in large cohorts and their
changes over time or in response to clinical interventions
in order to unveil specific pathogenetic pathways of PF&S
and identify new biological targets for drug development. In
particular, the retrieval of MDVs in serum of older adults
with PF&S has been associated with an innate immune
response. According to this theory, MDVs may function as
antigen-presenting vesicles carrying harmful material. Similar to
damage-associated molecular patterns (DAMPs), released from
injured cells, the MDV cargo can trigger caspase-1 activation
and the secretion of pro-inflammatory cytokines. Impaired
mitochondrial quality control in skeletal myocytes may therefore
generate a vicious circle favoring further mitochondrial damage
and the propagation of sterile inflammation through DAMPs
release. On this regard, the search of circulating mitochondrial
DAMPs in the elderly might be exploited for the development of
therapeutic interventions for PF&S.
In their mini-review, Kitada et al. discuss about the
close relationship existing between nutrients, autophagy and
lifespan. In particular the authors focussed their discussion on
methionine, an essential amino acid, because of its ability to
modulate autophagy through modulation of mTORC1 activity.
Recent studies have reported that protein restriction, rather
than calorie or dietary restriction, is strongly involved in the
lifespan extension and cardiometabolic health. Furthermore,
dietary methionine restriction may have a beneficial effect
on lifespan extension and metabolic health. Methionine may
activate mTORC1 and suppress autophagy. However, it has been
reported that mTORC1 may be activated by sensing S-adenosyl
methionine (SAM) rather thanmethionine and SAM, rather than
methionine, may be the main contributor to the aging process.
SAM has been also associated to insulin resistance and truncal
adiposity in elderly individuals. Therefore, the upregulation of
SAM associated with overfeeding or metabolic dysfunction may
be involved in whole-body metabolic impairment. Hence, the
suppression of mTORC1, induced by decreasing SAM levels, may
represent a therapeutic target for aging, age-related diseases and
metabolic impairment.
Last but not least, Thomas et al. report that many
clinical trials are evaluating the effectiveness of compounds
known to regulate autophagy in patients receiving anti-cancer
chemotherapy. In this primary study the authors aimed to
assess the effect of amino acid starvation on doxorubicin-treated
breast cancer cells by assessing the modulation of autophagy
and apoptosis. Indeed, many cancers are known to respond to
certain chemotherapeutics or to radiation therapy by increasing
autophagic activity. Although the role of autophagy in these
circumstances are still debatable, it appears that autophagy acts
predominantly as cell survival mediator. In their cell culture-
based studies the authors elegantly demonstrated a differential
protection of non-cancer cells and increased apoptosis in
cancer cells during chemotherapy when these cell lines with
high basal autophagy activity were starved of amino acids.
Altogether, these results suggest that short-term starvation
during doxorubicin chemotherapy may be a possible strategy
for adjuvant therapy, especially for the protection of non-
cancerous cells.
In conclusion in this Research Topic we have collected a
series of review and primary research article describing the close
relationships between autophagy and metabolism and we have
learnt that many questions are still unanswered and therefore
we encourage our colleagues to dedicate quality time onto this
fascinating area of research.
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